OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
Kyle Rosenke, Kimberly Meade‐White, Michael Letko, et al.
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 2673-2684
Open Access | Times Cited: 230

Showing 26-50 of 230 citing articles:

Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples
Yi-Chan Lin, Rebecca J. Malott, Linda Ward, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 55

Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model
Kyle Rosenke, Atsushi Okumura, Matthew Lewis, et al.
JCI Insight (2022) Vol. 7, Iss. 13
Open Access | Times Cited: 37

Hamster model for post-COVID-19 alveolar regeneration offers an opportunity to understand post-acute sequelae of SARS-CoV-2
L. Heydemann, Małgorzata Ciurkiewicz, Georg Beythien, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30

Infectious SARS-CoV-2 Is Emitted in Aerosol Particles
Seth A. Hawks, Aaron J. Prussin, Sarah C. Kuchinsky, et al.
mBio (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 50

Immune memory from SARS-CoV-2 infection in hamsters provides variant-independent protection but still allows virus transmission
Shu Horiuchi, Kohei Oishi, Lucía Carrau, et al.
Science Immunology (2021) Vol. 6, Iss. 66
Closed Access | Times Cited: 48

SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model
Bart L. Haagmans, Danny Noack, Nisreen M.A. Okba, et al.
The Journal of Infectious Diseases (2021) Vol. 223, Iss. 12, pp. 2020-2028
Open Access | Times Cited: 45

SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity
Michihito Sasaki, Shinsuke Toba, Yukari Itakura, et al.
mBio (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 43

Inactivation of SARS-CoV-2 Laboratory Specimens
Elaine Haddock, Friederike Feldmann, W. Lesley Shupert, et al.
American Journal of Tropical Medicine and Hygiene (2021) Vol. 104, Iss. 6, pp. 2195-2198
Open Access | Times Cited: 41

SARS-CoV-2 in animals: From potential hosts to animal models
Anna Michelitsch, Kerstin Wernike, Lorenz Ulrich, et al.
Advances in virus research (2021), pp. 59-102
Open Access | Times Cited: 40

Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models
Seyed Reza Banihashemi, Ali Es‐haghi, Mohammad Hossein Fallah Mehrabadi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern
David W. Hawman, Kimberly Meade‐White, Jacob Archer, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 32

Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization
Yunjeong Kim, Natasha N. Gaudreault, David A. Meekins, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 29

Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models
Shambhunath Choudhary, Isis Kanevsky, Soner Yildiz, et al.
Toxicologic Pathology (2022) Vol. 50, Iss. 3, pp. 280-293
Open Access | Times Cited: 27

Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies
Pia Gattinger, Anna Ohradanova‐Repic, Rudolf Valenta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5352-5352
Open Access | Times Cited: 19

Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant
Kathryn A. Ryan, Kevin R. Bewley, Robert J. Watson, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1011293-e1011293
Open Access | Times Cited: 18

Direct and indirect impact of SARS-CoV-2 on the brain
Jean Pierre Schatzmann Peron
Human Genetics (2023) Vol. 142, Iss. 8, pp. 1317-1326
Open Access | Times Cited: 17

Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control
Shen Wang, Wujian Li, Zhenshan Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6

Augmentation of Omicron BA.1 pathogenicity in hamsters using intratracheal inoculation
Julia R. Port, Claude Kwe Yinda, Claire Ruckel, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 5

Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model
Devanshi R. Patel, Allen M. Minns, Derek G. Sim, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 5

Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology
Arthur Wickenhagen, Meaghan Flagg, Julia R. Port, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Animal Models for Human-Pathogenic Coronavirus and Animal Coronavirus Research
Fenglian Xiao, Jincheng Hu, Minsheng Xu, et al.
Viruses (2025) Vol. 17, Iss. 1, pp. 100-100
Open Access

Scroll to top